Heterozygous mutations in Fanconi anemia genes predispose AA and MDS patients to BMF and leukemogenesis [32], and heterozygosity for the 258 + 2 T >C SBDS mutation appears to be another genetic factor accelerating telomere shortening in aAA patients [33]. The gene discussed is SBDS; the disease is myelodysplastic syndrome.